Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide (NO) release is the biological process by which nitric oxide, a gaseous signaling molecule, is produced and liberated from cells. NO plays critical roles in vascular tone regulation, neurotransmission, immune response modulation, and other physiological processes. It is synthesized primarily from L-arginine by nitric oxide synthases (NOS) but can also arise from non-enzymatic sources. NO is not stored but synthesized on demand and diffuses freely across cell membranes to exert its effects.
Primarily enzymatic synthesis from L-arginine by nitric oxide synthases (nNOS, iNOS, eNOS), leading to diffusion across cell membranes and activation of downstream targets like soluble guanylyl cyclase (sGC). Can also occur non-enzymatically via nitrite reduction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide Release (None).